Indian stocks: Visit www.stage2stocks.com →

Korsana Biosciences, Inc.

Stage 2 · Advancing · week 26

As of Oct 22, 2026, Korsana Biosciences is in Stage 2, the uptrend phase, now in week 26 (since Apr 23, 2026). It closed at $33.43, 25.1% below its 52-week high and above its 200-day average, which is rising.

Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases. More about the company

$33.43
+2.74% today
$1.5B · Small cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care

Is KRSA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 20w
S4 32w
S2 26w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 20w → S1 10w → S4 7w → S1 2w → S4 11w → S1 6w → S2 1w → S1 2w → S4 10w → S1 3w → S2 9w → S3 6w → S4 4w → S1 1w → S2 9w → S3 3w → S4 32w → S1 3w → S2 26w current
Total tracked: 165 weeks across 19 stage runs.

KRSA among Biotechnology38th of 591 by relative strength

All 591 →
Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#StockStageRS1M
1GTBPStage 2 · wk 799−22.3%
2IOVAStage 2 · wk 1899+38.8%
3SLSStage 3 · wk 499−1.5%
4MRNAStage 2 · wk 1799+11.3%
5TWSTStage 2 · wk 3999−14.5%
6KODStage 2 · wk 499+172.1%
7ERASStage 3 · wk 599+0.7%
8CLYMStage 3 · wk 399−15.8%
…38KRSAStage 2 · wk 2696+3.5%
vs 52W High
-25.1%
$7.56 lo$44.66 hi
25.1% below 52W high, far from high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 26
1w13w26w
Week 26, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
56.3%
200 DMA: $21.39 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.40x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+3.5%
3M
+36.4%
6M
+61.9%
YTD
+256.4%
1Y
+121.1%
Scan Membership
Breakout Watch
Latest: 2025-05-27
5 appearances in last 60 days. First seen: 2020-07-02.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 26 · Vol 1.40x
2026-10-21S2
Wk 26 · Vol 1.99x
2026-10-20S2
Wk 25 · Vol 1.71x
2026-10-19S2
Wk 25 · Vol 6.27x
2026-10-16S2
Wk 25 · Vol 2.13x
2026-10-15S2
Wk 25 · Vol 3.55x
2026-10-14S2
Wk 25 · Vol 4.24x
2026-10-13S2
Wk 24 · Vol 4.04x
2026-10-12S2
Wk 24 · Vol 1.44x
2026-10-09S2
Wk 24 · Vol 1.14x
2026-10-08S2
Wk 24 · Vol 5.34x
2026-10-07S2
Wk 24 · Vol 1.04x
Moving averages & range
50 DMA
$30.77
200 DMA
$21.39
52W High
$44.66
52W Low
$7.56
5D Low
$31.03
Resistance levels (recent highs)
20d High
$34.32
60d High
$37.19
120d High
$37.19
250d High
$44.66
Next resistance
+2.7%
to 20d High
Dividend Yield
0.00%
P/B -4.3

Korsana Biosciences: quick answers

What stage is Korsana Biosciences in?

As of Oct 22, 2026, Korsana Biosciences (KRSA) is in Stage 2, the uptrend phase. It entered Stage 2 on Apr 23, 2026 and is in week 26. What the four stages mean

Is Korsana Biosciences in an uptrend?

Yes. Korsana Biosciences is in a Stage 2 uptrend. It trades 56.3% above its 200-day average, which is rising.

How far is Korsana Biosciences from its 52-week high?

Korsana Biosciences closed at $33.43 on Oct 22, 2026, 25.1% below its 52-week high of $44.66. Its 52-week low is $7.56.

How has Korsana Biosciences performed over the past year?

As of Oct 22, 2026, Korsana Biosciences is up 121.1% over the past year and up 256.4% so far in 2026.

Which sector and industry is Korsana Biosciences in?

Korsana Biosciences is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases. The company has developed Therapeutic Targeting (THETA), a blood-brain barrier-penetrant shuttle platform designed to enhance central nervous system exposure of investigational therapies and enable delivery of large therapeutic molecules across the blood-brain barrier into the central nervous system. The company advances a pipeline of THETA-enabled therapeutics with an initial focus on neurodegenerative disorders. Its lead product candidate is KRSA-028, an anti-amyloid beta antibody for the treatment of Alzheimer's disease, which combines the THETA platform with elements of anti-amyloid beta approaches and targets a clinically relevant form of amyloid beta designed to improve brain uptake while reducing effects on reticulocytes. The company is also advancing a pipeline of additional THETA-enabled therapies for other neurodegenerative diseases. Korsana Biosciences, Inc. was incorporated in 2024 and is based in Waltham, Massachusetts.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.